Login
$NTRA
$410.82 +$5.92 (1.46%) Close

$NTRA 4 SEC Filings

Filed On Filing
23 Oct 2026 Form 4: Sheena Jonathan, Director

Sold 3,150 shares ($1.29M)

20 Oct 2026 Form 4: Sheena Jonathan, Director

Sold 1,500 shares ($604K)

16 Oct 2026 Form 4: Rabinowitz Matthew, Director

Received 50,000 shares by exercise or conversion ($521K) · Sold 49,400 shares ($19.9M) · Sold 600 shares ($239K)

09 Oct 2026 Form 4: Rabinowitz Matthew, Director

Gave 6,000 shares as a gift

02 Oct 2026 Form 4: Moshkevich Solomon, PRESIDENT, CLINICALDIAGNOSTICS

Sold 3,000 shares ($1.24M)

02 Oct 2026 Form 4: Chapman Steven Leonard, Director

Sold 1,273 shares ($526K)

25 Sep 2026 Form 4: Sheena Jonathan, Director

Sold 18,064 shares ($7.01M)

18 Sep 2026 Form 4: Moshkevich Solomon, PRESIDENT, CLINICALDIAGNOSTICS

Gave 945 shares as a gift

17 Sep 2026 Form 4: Sheena Jonathan, Director

Sold 6,000 shares ($2.1M) · Sold 3,150 shares ($1.12M)

16 Sep 2026 Form 4: Rabinowitz Matthew, Director

Sold 50,000 shares ($16.7M) · Sold 52,000 shares ($18.1M)

11 Sep 2026 Form 4: Rabinowitz Matthew, Director

Sold 50,000 shares ($16.4M)

03 Sep 2026 Form 4: Moshkevich Solomon, PRESIDENT, CLINICALDIAGNOSTICS

Sold 3,000 shares ($962K) · Sold 15,160 shares ($4.96M)

03 Sep 2026 Form 4: Chapman Steven Leonard, Director

Sold 1,698 shares ($545K)

28 Aug 2026 Form 4: Fesko John, PRESIDENT, CHIEF BUS. OFFICER

Received 20,000 shares as a grant or award · Sold 6,517 shares ($2.1M)

14 Aug 2026 Form 4: Sheena Jonathan, Director

Sold 6,000 shares ($1.95M)

07 Aug 2026 Form 4: Rabinowitz Matthew, Director

Sold 2,000 shares ($642K)

07 Aug 2026 Form 4: Sheena Jonathan, Director

Sold 9,150 shares ($2.89M)

05 Aug 2026 Form 4: Brophy Michael Burkes, CHIEF FINANCIAL OFFICER

Sold 317 shares ($85K) · Sold 478 shares ($131K)

05 Aug 2026 Form 4: Chapman Steven Leonard, Director

Sold 3,076 shares ($819K)

05 Aug 2026 Form 4: Fesko John, PRESIDENT, CHIEF BUS. OFFICER

Sold 295 shares ($79.1K)

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support